ResourcesComparison

TipRanks Alternatives: 5 Ways to Track Which Analysts Are Actually Right

TipRanks made analyst track records mainstream. These alternatives cover the same question, which Wall Street calls are worth listening to, from different angles and price points.

Exent Research7 min read

Key takeaways

  • TipRanks ranks 96,000+ experts by success rate, average return and statistical significance; it is still the broadest.
  • Exent: analyst accuracy tied to a short list of stocks where the best-rated analysts agree, plus a check of your own portfolio.
  • WallStreetZen: the closest like-for-like, with 4,000+ analysts tracked and lower annual pricing.
  • Seeking Alpha and Zacks: quant ratings and research rather than analyst league tables.

What TipRanks does well

TipRanks tracks and ranks more than 96,000 financial experts. Its analyst star ranking combines three factors: success rate (the share of ratings that produced a positive return), average return per rating, and statistical significance (more ratings, more confidence). It also offers a 1–10 Smart Score built from eight factors, from analyst ratings to insider trades and technicals.

Paid plans are sold mainly on annual billing; third-party reviews in 2026 put them at roughly $360–$600 a year, with frequent discounts. Check the current price on TipRanks before buying.

Why people look for alternatives

  • Breadth can be overwhelming. Tens of thousands of experts and scores for every ticker still leave you to decide what to buy.
  • Price. Some alternatives cost less per year.
  • No link to your portfolio. Knowing an analyst is accurate does not tell you whether their pick fits what you already own.

Quick comparison

ToolAnalyst trackingWhat else you getPrice (Oct 2026)
TipRanks96,000+ experts, star rankingSmart Score, insider and hedge fund dataAbout $360–$600/yr (third-party figures)
Exent4,000+ analysts ranked by past accuracyCurated Gems, portfolio risk analysis, market intel$1.95 3-day trial, then $59/month
WallStreetZen4,000+ analysts, top-analyst filtersZen Ratings (A–F) on 4,600+ stocksFree; Premium $19.50/mo billed yearly
Seeking AlphaSell-side and author ratings shownQuant Ratings, articles, transcriptsPremium $299/yr, 7-day trial
ZacksNot the focusZacks Rank, Style ScoresFree tier; Premium about $249/yr
Morningstar InvestorNot the focusAnalyst research, fund ratings, X-Ray$249/yr or $34.95/mo

1. Exent: analyst accuracy that ends in a short list

Exent’s Stocks Radar tracks 4,000+ Wall Street analysts, ranks them by how their past calls actually played out, and surfaces Gems: stocks where the best-rated analysts agree, each with a written thesis. Instead of a score for every ticker, you get a short list built from the people with the best records.

The same membership includes a full risk analysis of your portfolio, so you can see whether a new idea adds diversification or doubles a risk you already carry.

Where TipRanks is better: far broader coverage (bloggers, insiders, hedge funds) and a score on every stock.

2. WallStreetZen: the closest like-for-like

WallStreetZen tracks the returns of 4,000+ analysts. Premium unlocks unlimited analyst performance pages, following up to 200 analysts and filtering forecasts to top analysts. Its Zen Ratings grade 4,600+ stocks A to F daily using 115 factors. Premium is $19.50 a month billed yearly, with a $1 14-day trial.

3. Seeking Alpha: ratings plus research

Seeking Alpha Premium shows Quant, author and sell-side ratings side by side, with factor grades, unlimited articles and earnings call transcripts, screeners and portfolio tools. It suits investors who want to read the debate around a stock rather than a league table of analysts. Premium is $299 a year with a 7-day trial.

4. Zacks: a quant ranking with a long history

Zacks Rank is built mainly on earnings estimate revisions, and the free tier shows it on every ticker. Premium unlocks the full lists and research. It is less about which analyst is right and more about where estimates are moving.

5. Morningstar Investor: independent research

If what you want is independent analysis rather than a scorecard of sell-side analysts, Morningstar’s own analyst research, fair value estimates and fund ratings are a different but credible route. $249 a year or $34.95 a month, with a 7-day trial.

Which one should you pick?

  • Maximum coverage and a score for every stock: stay with TipRanks.
  • A short list from the most accurate analysts, checked against your own portfolio: Exent.
  • TipRanks-style tracking for less per year: WallStreetZen.
  • Ratings plus deep reading: Seeking Alpha.

Frequently asked questions

WallStreetZen and Zacks both have free tiers with limited analyst and rating data. Full analyst-tracking features are paid on every platform.

By three factors: success rate (share of ratings with a positive return), average return per rating, and statistical significance based on the number of ratings.

Accuracy varies widely between analysts, which is why tracking individual records matters more than following the average target.

Exent focuses on a short list of stocks where the best-rated analysts agree, and pairs it with a risk analysis of your own portfolio. TipRanks covers far more experts and stocks.

See which stocks the most accurate analysts agree on.

Stocks Radar ranks 4,000+ analysts by their past calls and surfaces the Gems where the best ones agree.

See this week’s GemsLimited offer$1.95 for full Gems access· full Gems access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.